Dietary supplement recalled, FDA says

Silintan capsules are recalled after the Food and Drug Administration found they were tainted with another drug.
MedPage Today on MSN

FDA moves to 'get out of the way' of wearables, AI in the clinic

Torous noted that over the summer, a company called WHOOP received an FDA warning letter over a product that could measure ...

FDA approves Myqorzo for symptomatic obstructive hypertrophic cardiomyopathy

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
BioSpace

Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...
IEEE

KITE-DDI: A Knowledge Graph Integrated Transformer Model for Accurately Predicting Drug-Drug Interaction Events From Drug SMILES and Biomedical Knowledge Graph

Abstract: It is a common practice in modern medicine to prescribe multiple medications simultaneously to treat diseases. However, these medications could have adverse reactions between them, known as ...
ProPublica

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
CNN

With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...